160 Health International Limited (Stock Code: 02656) announced a positive profit alert, projecting an adjusted net profit (non-IFRS) of RMB3.00 million to RMB5.00 million for the financial year ended 31 December 2025. This represents a sharp turnaround from the adjusted net loss of RMB31.50 million recorded in FY2024 and would mark the Group’s first full-year profit on an adjusted basis.

Management attributes the swing to profit chiefly to: 1. Year-on-year revenue growth that lifted gross profit. 2. Refined management practices and continual operational-efficiency gains that materially reduced total operating expenses spanning selling and marketing, research and development, and administrative functions.

The company defines “adjusted net profit” as profit for the year before adding back share-based compensation and listing expenses—two non-cash or non-operational items the Board believes could obscure the underlying performance.

The figures are derived from the Group’s unaudited consolidated management accounts and remain subject to audit, review by the Company’s audit committee, and potential adjustments. The full FY2025 results are scheduled for release by end-March 2026.

Shareholders and prospective investors are urged to exercise caution when dealing in the Company’s shares until the audited results are published.